Sorted By:

Relevance


Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

PhRMA  |  Blog Post

Learn more about why drug importation is bad for patients here.
http://catalyst.phrma.org/discovery-of-counterfeit-hepatitis-c-drug-is-another-example-of-why-importation-is-bad-for-patients

PPA: More than just prescription assistance

PhRMA  |  Blog Post

PPA Video PPA Brochure
http://catalyst.phrma.org/ppa-more-than-just-prescription-assistance

Medicare Monday: Positive impact of Part D on America’s seniors

PhRMA  |  Blog Post

Learn more about Medicare Part D at PhRMA.org/PartD.
http://catalyst.phrma.org/medicare-monday-positive-impact-of-part-d-on-americas-seniors

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

The platform can be viewed online here: http://phrma.org/sites/default/files/policy-solutions.pdf.
https://www.phrma.org

Las Compañías Biofarmacéuticas de Estados Unidos Lanzan una Innovadora Iniciativa Anunciando la Nueva Era de la Medicina

PhRMA  |  Press Release

Desde el año 2000, las empresas miembros de PhRMA han invertido más de medio trillón de dólares en la búsqueda de nuevos tratamientos y curas, incluyendo un estimado de $58.8 mil millones en el año 2015 por sí solo.
https://www.phrma.org/press-release/las-compa-as-biofarmac-uticas-de-estados-unidos-lanzan-una-innovadora-iniciativa-anunciando-la-nueva-era-de-la-medicina

Medicare Monday: Another example of the competitive market at work in Part D

PhRMA  |  Blog Post

The higher annual percentage increase in the last couple years was attributed in part to the availability of new hepatitis C treatments.
http://catalyst.phrma.org/medicare-monday-another-example-of-the-competitive-market-at-work-in-part-d

Medicare Monday: Study finds mortality rates for elderly have decreased every year since creation of Part D

PhRMA  |  Blog Post

Today, the Part D program is helping more than 40 million seniors live longer, healthier lives.
http://catalyst.phrma.org/medicare-monday-study-finds-mortality-rates-for-elderly-have-decreased-every-year-since-creation-of-part-d

New data put medicine costs and spending in context

PhRMA  |  Blog Post

Biopharmaceutical companies invested about $75 billion in research and development (R&D) in 2015 and, on average, reinvest 20 percent of revenues into R&D.
http://catalyst.phrma.org/new-data-put-medicine-costs-and-spending-in-context

The Story of Pat Scannon, Chief Scientific Officer, Xoma

PhRMA  |  Video

." - The story of Pat Scannon, Chief Scientific Officer at Xoma.
https://www.phrma.org/video/the-story-of-pat-scannon-chief-scientific-officer-xoma

Getting What You Pay for in the ACA

Access Better Coverage  |  From Our Network

The Medicare Part D prescription drug program has such a feature, and it's proven hugely helpful to seniors.
http://www.accessbettercoverage.org/social-news/getting-what-you-pay-for-in-the-aca

New research: Insurance plan structure can have discriminatory effect

PhRMA  |  Blog Post

They note, “This insurance practice has the discriminatory effect of discouraging individuals in need of specific medications from enrolling in these plans or of shifting the burden of the cost back to these enrollees.
http://catalyst.phrma.org/new-research-insurance-plan-structure-can-have-discriminatory-effect

She Has Health Insurance, But Can't Pay Her Medical Bills. She's Not Alone.

Access Better Coverage  |  From Our Network

She adds, "my car insurance may reimburse me for some of it after I'm done with treatment, but I don't know when that will be."
http://www.accessbettercoverage.org/social-news/she-has-health-insurance-but-cant-pay-her-medical-bills

Home Page

PhRMA  |  From PhRMA

The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies....
https://www.phrma.org/

Paul Gileno

PhRMA  |  Biography

In May 2014, he was the recipient of the Unsung Hero Award for his stellar work in pain policy initiatives as well as his significant contributions to advance the social awareness of pain and suffering.
https://www.phrma.org/biography/paul-gileno

Hospitals Receive from Commercial Payers 2.5x What They Paid to Acquire These Medicines

PhRMA  |  Graphic

The analysis of 20 medicines also found the amount hospitals receive from commercial payers is 250 percent what they paid to acquire these medicines. 
https://www.phrma.org/graphic/hospitals-receive-from-commercial-payers-2-5x-what-they-paid-to-acquire-these-medicines

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

PhRMA  |  Blog Post

Learn more about Medicare Part D and the importance of ensuring the program continues to provide seniors and individuals with disabilities access to affordable prescription drug coverage.
http://catalyst.phrma.org/medicare-monday-how-government-price-setting-in-part-d-could-reduce-innovation-shorten-life-expectancy-for-beneficiaries

Mae Jemison

PhRMA  |  Biography

She is a highly sought after speaker on issues including health care, social responsibility, technology and motivation and has provided commentary for the BBC, McNeil Lehrer Report, ABC Nightline, NPR and CNN.
https://www.phrma.org/biography/mae-jemison

How much are hospitals marking up the price of medicines? The answer may surprise you.

PhRMA  |  Blog Post

Even after negotiations with commercial payers, hospitals are often paid tens of thousands of dollars more than the amount the hospital paid to buy the medicine.
http://catalyst.phrma.org/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you

Medicare Monday: New study further confirms increased use of generics after Part D

PhRMA  |  Blog Post

Since its implementation in 2006, the program has continued to ensure that beneficiaries have affordable access to the prescription medicines they need.
http://catalyst.phrma.org/medicare-monday-new-study-further-confirms-increased-use-of-generics-after-part-d

Many Say High Deductibles Make Their Health Law Insurance All but Useless

Access Better Coverage  |  From Our Network

I’m better off not purchasing that insurance and saving the money in case something bad happens.
http://www.accessbettercoverage.org/social-news/many-say-high-deductibles-make-their-health-law-insurance-all-but-useless

Paul Fonteyne

PhRMA  |  Biography


https://www.phrma.org/biography/paul-fonteyne

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

For more, be sure to check out: What They Are Saying about New Hep C Cure: “That's actually a great deal” ICYMI: Insurer: “Can drugs as expensive as these really be cost-effective?
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

Innovation comes in many forms, including new and expanded uses of existing medicines

PhRMA  |  Blog Post

This new technology has the potential to help patients take their medicine as prescribed, which is critically important in patients with these difficult to treat conditions.
http://catalyst.phrma.orghttps://catalyst.phrma.org/innovation-comes-in-many-forms-including-new-and-expanded-uses-of-existing-medicines

Ian Read

PhRMA  |  Biography

Ian serves on the Board of Kimberly-Clark as well as on the U.S.
https://www.phrma.org/biography/ian-read1

Lisa M. Tate, CAE

PhRMA  |  Biography

Since her arrival in 2007, WomenHeart: The National Coalition for Women with Heart Disease has multiplied its collaborations with health providers, corporate partners and non-profit allies, enabling it to expand the number of community-based support groups, online patient support services and its unique, national network of WomenHeart Champions.
https://www.phrma.org/biography/lisa-m-tate-cae

You have reviewed the first 75 results out of 2221. Each page contains 25 results. You're on page 3.

prev 1 2 3 4 5 6 next